© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists
REVIEW
Amyloid in the cardiovascular system: a review
Department of Pathology, Vrije Universiteit Medical Centre, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands
Correspondence to:
Correspondence to:
Dr H W M Niessen
Vrije Universiteit Medical Centre, Department of Pathology, De Boelelaan 1117, Room 1B116, 1007 MB Amsterdam, The Netherlands; jwm.niessen{at}vumc.nl
The cardiovascular system is a common target of amyloidosis. This review presents the current clinical and diagnostic approach to amyloidosis, with the emphasis on cardiovascular involvement. It summarises recent nomenclature, classification, and pathogenesis of amyloidosis. In addition, non-invasive possibilities are discussed, together with endomyocardial biopsies in the diagnosis of cardiac amyloidosis. Finally, recent advances in treatment and prognostic implications are presented.
Abbreviations: ANF, atrial natriuretic factor; IAA, isolated atrial amyloidosis; SAA, serum amyloid A; SSA, systemic senile amyloidosis; TTR, transthyretin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
